ES2624805T3 - Mutantes mejorados de glucosa deshidrogenasa soluble dependiente de pirroloquinolina quinona - Google Patents
Mutantes mejorados de glucosa deshidrogenasa soluble dependiente de pirroloquinolina quinona Download PDFInfo
- Publication number
- ES2624805T3 ES2624805T3 ES07724148.7T ES07724148T ES2624805T3 ES 2624805 T3 ES2624805 T3 ES 2624805T3 ES 07724148 T ES07724148 T ES 07724148T ES 2624805 T3 ES2624805 T3 ES 2624805T3
- Authority
- ES
- Spain
- Prior art keywords
- mutant
- glucose
- gdh
- amino acid
- maltose
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 230000001419 dependent effect Effects 0.000 title abstract description 8
- 108040005045 glucose dehydrogenase activity proteins Proteins 0.000 title description 2
- MMXZSJMASHPLLR-UHFFFAOYSA-N pyrroloquinoline quinone Chemical compound C12=C(C(O)=O)C=C(C(O)=O)N=C2C(=O)C(=O)C2=C1NC(C(=O)O)=C2 MMXZSJMASHPLLR-UHFFFAOYSA-N 0.000 title 2
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 abstract description 55
- 239000008103 glucose Substances 0.000 abstract description 55
- 101000806049 Acinetobacter calcoaceticus Quinoprotein glucose dehydrogenase B Proteins 0.000 abstract description 42
- 235000001014 amino acid Nutrition 0.000 abstract description 42
- 150000001413 amino acids Chemical group 0.000 abstract description 39
- 238000006467 substitution reaction Methods 0.000 abstract description 27
- OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 abstract description 24
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 abstract description 24
- GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 abstract description 24
- 230000035772 mutation Effects 0.000 abstract description 17
- 239000004471 Glycine Substances 0.000 abstract description 13
- QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 abstract description 12
- 235000004279 alanine Nutrition 0.000 abstract description 12
- FWMNVWWHGCHHJJ-SKKKGAJSSA-N 4-amino-1-[(2r)-6-amino-2-[[(2r)-2-[[(2r)-2-[[(2r)-2-amino-3-phenylpropanoyl]amino]-3-phenylpropanoyl]amino]-4-methylpentanoyl]amino]hexanoyl]piperidine-4-carboxylic acid Chemical compound C([C@H](C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N1CCC(N)(CC1)C(O)=O)NC(=O)[C@H](N)CC=1C=CC=CC=1)C1=CC=CC=C1 FWMNVWWHGCHHJJ-SKKKGAJSSA-N 0.000 abstract description 10
- 102220474575 Ubiquitin-conjugating enzyme E2 D1_D87R_mutation Human genes 0.000 abstract description 9
- 241000588624 Acinetobacter calcoaceticus Species 0.000 abstract description 8
- MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Natural products OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 abstract description 8
- AYFVYJQAPQTCCC-UHFFFAOYSA-N Threonine Natural products CC(O)C(N)C(O)=O AYFVYJQAPQTCCC-UHFFFAOYSA-N 0.000 abstract description 7
- 239000004473 Threonine Substances 0.000 abstract description 7
- 125000000341 threoninyl group Chemical group [H]OC([H])(C([H])([H])[H])C([H])(N([H])[H])C(*)=O 0.000 abstract description 7
- MTCFGRXMJLQNBG-REOHCLBHSA-N (2S)-2-Amino-3-hydroxypropansäure Chemical compound OC[C@H](N)C(O)=O MTCFGRXMJLQNBG-REOHCLBHSA-N 0.000 abstract description 6
- 108010050375 Glucose 1-Dehydrogenase Proteins 0.000 abstract description 5
- 229940024606 amino acid Drugs 0.000 description 31
- 239000000758 substrate Substances 0.000 description 23
- 230000000694 effects Effects 0.000 description 21
- 235000000346 sugar Nutrition 0.000 description 9
- 238000000034 method Methods 0.000 description 8
- 102000004190 Enzymes Human genes 0.000 description 6
- 108090000790 Enzymes Proteins 0.000 description 6
- 229940088598 enzyme Drugs 0.000 description 6
- 238000005259 measurement Methods 0.000 description 5
- ONIBWKKTOPOVIA-BYPYZUCNSA-N L-Proline Chemical compound OC(=O)[C@@H]1CCCN1 ONIBWKKTOPOVIA-BYPYZUCNSA-N 0.000 description 4
- ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 description 4
- ONIBWKKTOPOVIA-UHFFFAOYSA-N Proline Natural products OC(=O)C1CCCN1 ONIBWKKTOPOVIA-UHFFFAOYSA-N 0.000 description 4
- 230000009260 cross reactivity Effects 0.000 description 4
- 230000002255 enzymatic effect Effects 0.000 description 4
- 108020004414 DNA Proteins 0.000 description 3
- OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 description 3
- 238000001514 detection method Methods 0.000 description 3
- -1 leucine amino acid Chemical class 0.000 description 3
- COLNVLDHVKWLRT-UHFFFAOYSA-N phenylalanine Natural products OC(=O)C(N)CC1=CC=CC=C1 COLNVLDHVKWLRT-UHFFFAOYSA-N 0.000 description 3
- COLNVLDHVKWLRT-QMMMGPOBSA-N phenylalanine group Chemical group N[C@@H](CC1=CC=CC=C1)C(=O)O COLNVLDHVKWLRT-QMMMGPOBSA-N 0.000 description 3
- 230000009257 reactivity Effects 0.000 description 3
- 238000012216 screening Methods 0.000 description 3
- 238000012360 testing method Methods 0.000 description 3
- OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 description 3
- DCXYFEDJOCDNAF-UHFFFAOYSA-N Asparagine Natural products OC(=O)C(N)CC(N)=O DCXYFEDJOCDNAF-UHFFFAOYSA-N 0.000 description 2
- 241000588724 Escherichia coli Species 0.000 description 2
- FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 description 2
- KZSNJWFQEVHDMF-UHFFFAOYSA-N Valine Natural products CC(C)C(N)C(O)=O KZSNJWFQEVHDMF-UHFFFAOYSA-N 0.000 description 2
- 235000009582 asparagine Nutrition 0.000 description 2
- 229960001230 asparagine Drugs 0.000 description 2
- 235000003704 aspartic acid Nutrition 0.000 description 2
- CKLJMWTZIZZHCS-REOHCLBHSA-N aspartic acid group Chemical group N[C@@H](CC(=O)O)C(=O)O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 description 2
- OQFSQFPPLPISGP-UHFFFAOYSA-N beta-carboxyaspartic acid Natural products OC(=O)C(N)C(C(O)=O)C(O)=O OQFSQFPPLPISGP-UHFFFAOYSA-N 0.000 description 2
- GUBGYTABKSRVRQ-QUYVBRFLSA-N beta-maltose Chemical compound OC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O)[C@H](O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@@H]1O GUBGYTABKSRVRQ-QUYVBRFLSA-N 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- 239000003153 chemical reaction reagent Substances 0.000 description 2
- 238000010367 cloning Methods 0.000 description 2
- 238000011156 evaluation Methods 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 125000003630 glycyl group Chemical group [H]N([H])C([H])([H])C(*)=O 0.000 description 2
- HNDVDQJCIGZPNO-UHFFFAOYSA-N histidine Natural products OC(=O)C(N)CC1=CN=CN1 HNDVDQJCIGZPNO-UHFFFAOYSA-N 0.000 description 2
- 229930182817 methionine Natural products 0.000 description 2
- 238000000746 purification Methods 0.000 description 2
- 150000008163 sugars Chemical class 0.000 description 2
- 239000004474 valine Substances 0.000 description 2
- 239000013598 vector Substances 0.000 description 2
- 241000588626 Acinetobacter baumannii Species 0.000 description 1
- 239000004475 Arginine Substances 0.000 description 1
- 239000004593 Epoxy Substances 0.000 description 1
- 108010015776 Glucose oxidase Proteins 0.000 description 1
- 239000004366 Glucose oxidase Substances 0.000 description 1
- WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 description 1
- DCXYFEDJOCDNAF-REOHCLBHSA-N L-asparagine Chemical group OC(=O)[C@@H](N)CC(N)=O DCXYFEDJOCDNAF-REOHCLBHSA-N 0.000 description 1
- ZDXPYRJPNDTMRX-VKHMYHEASA-N L-glutamine Chemical group OC(=O)[C@@H](N)CCC(N)=O ZDXPYRJPNDTMRX-VKHMYHEASA-N 0.000 description 1
- HNDVDQJCIGZPNO-YFKPBYRVSA-N L-histidine Chemical compound OC(=O)[C@@H](N)CC1=CN=CN1 HNDVDQJCIGZPNO-YFKPBYRVSA-N 0.000 description 1
- AGPKZVBTJJNPAG-WHFBIAKZSA-N L-isoleucine Chemical group CC[C@H](C)[C@H](N)C(O)=O AGPKZVBTJJNPAG-WHFBIAKZSA-N 0.000 description 1
- ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical group CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 description 1
- QIVBCDIJIAJPQS-VIFPVBQESA-N L-tryptophane Chemical group C1=CC=C2C(C[C@H](N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-VIFPVBQESA-N 0.000 description 1
- KZSNJWFQEVHDMF-BYPYZUCNSA-N L-valine Chemical compound CC(C)[C@H](N)C(O)=O KZSNJWFQEVHDMF-BYPYZUCNSA-N 0.000 description 1
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 1
- 239000004472 Lysine Substances 0.000 description 1
- 108091028043 Nucleic acid sequence Proteins 0.000 description 1
- QIVBCDIJIAJPQS-UHFFFAOYSA-N Tryptophan Chemical group C1=CC=C2C(CC(N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-UHFFFAOYSA-N 0.000 description 1
- 238000001042 affinity chromatography Methods 0.000 description 1
- WQZGKKKJIJFFOK-PHYPRBDBSA-N alpha-D-galactose Chemical compound OC[C@H]1O[C@H](O)[C@H](O)[C@@H](O)[C@H]1O WQZGKKKJIJFFOK-PHYPRBDBSA-N 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 1
- 125000000637 arginyl group Chemical group N[C@@H](CCCNC(N)=N)C(=O)* 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- 238000012512 characterization method Methods 0.000 description 1
- 238000010276 construction Methods 0.000 description 1
- 238000012937 correction Methods 0.000 description 1
- 239000000287 crude extract Substances 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 238000004520 electroporation Methods 0.000 description 1
- 108010011035 endodeoxyribonuclease DpnI Proteins 0.000 description 1
- 239000013604 expression vector Substances 0.000 description 1
- 230000002349 favourable effect Effects 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 229930182830 galactose Natural products 0.000 description 1
- 238000001641 gel filtration chromatography Methods 0.000 description 1
- 229940116332 glucose oxidase Drugs 0.000 description 1
- 235000019420 glucose oxidase Nutrition 0.000 description 1
- 235000013922 glutamic acid Nutrition 0.000 description 1
- 239000004220 glutamic acid Substances 0.000 description 1
- ZDXPYRJPNDTMRX-UHFFFAOYSA-N glutamine Chemical group OC(=O)C(N)CCC(N)=O ZDXPYRJPNDTMRX-UHFFFAOYSA-N 0.000 description 1
- 235000004554 glutamine Nutrition 0.000 description 1
- 125000000487 histidyl group Chemical group [H]N([H])C(C(=O)O*)C([H])([H])C1=C([H])N([H])C([H])=N1 0.000 description 1
- 238000003780 insertion Methods 0.000 description 1
- 230000037431 insertion Effects 0.000 description 1
- 230000000968 intestinal effect Effects 0.000 description 1
- 238000004255 ion exchange chromatography Methods 0.000 description 1
- AGPKZVBTJJNPAG-UHFFFAOYSA-N isoleucine Chemical group CCC(C)C(N)C(O)=O AGPKZVBTJJNPAG-UHFFFAOYSA-N 0.000 description 1
- 229960000310 isoleucine Drugs 0.000 description 1
- 125000001909 leucine group Chemical group [H]N(*)C(C(*)=O)C([H])([H])C(C([H])([H])[H])C([H])([H])[H] 0.000 description 1
- 125000003588 lysine group Chemical group [H]N([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])(N([H])[H])C(*)=O 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 239000002773 nucleotide Substances 0.000 description 1
- 125000003729 nucleotide group Chemical group 0.000 description 1
- 229910052762 osmium Inorganic materials 0.000 description 1
- SYQBFIAQOQZEGI-UHFFFAOYSA-N osmium atom Chemical compound [Os] SYQBFIAQOQZEGI-UHFFFAOYSA-N 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 238000010647 peptide synthesis reaction Methods 0.000 description 1
- 239000013612 plasmid Substances 0.000 description 1
- 108091033319 polynucleotide Proteins 0.000 description 1
- 239000002157 polynucleotide Substances 0.000 description 1
- 102000040430 polynucleotide Human genes 0.000 description 1
- 229920001184 polypeptide Polymers 0.000 description 1
- 230000008092 positive effect Effects 0.000 description 1
- 102000004196 processed proteins & peptides Human genes 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
- 238000001742 protein purification Methods 0.000 description 1
- 108091008146 restriction endonucleases Proteins 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 238000002741 site-directed mutagenesis Methods 0.000 description 1
- 238000010561 standard procedure Methods 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
- 125000002987 valine group Chemical group [H]N([H])C([H])(C(*)=O)C([H])(C([H])([H])[H])C([H])([H])[H] 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C12N15/52—Genes encoding for enzymes or proenzymes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/0004—Oxidoreductases (1.)
- C12N9/0006—Oxidoreductases (1.) acting on CH-OH groups as donors (1.1)
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Genetics & Genomics (AREA)
- Engineering & Computer Science (AREA)
- Zoology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Wood Science & Technology (AREA)
- Organic Chemistry (AREA)
- Biomedical Technology (AREA)
- General Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Molecular Biology (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Physics & Mathematics (AREA)
- Biophysics (AREA)
- Plant Pathology (AREA)
- Enzymes And Modification Thereof (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Apparatus Associated With Microorganisms And Enzymes (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP06007779 | 2006-04-13 | ||
| EP06007779 | 2006-04-13 | ||
| PCT/EP2007/003207 WO2007118647A1 (en) | 2006-04-13 | 2007-04-11 | Improved mutants of pyrroloquinoline quinone dependent soluble glucose dehydrogenase |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ES2624805T3 true ES2624805T3 (es) | 2017-07-17 |
Family
ID=36579921
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ES07724148.7T Active ES2624805T3 (es) | 2006-04-13 | 2007-04-11 | Mutantes mejorados de glucosa deshidrogenasa soluble dependiente de pirroloquinolina quinona |
| ES17151869T Active ES2807530T3 (es) | 2006-04-13 | 2007-04-11 | Mutantes mejorados de glucosa deshidrogenasa soluble dependiente de pirroloquinolina quinona |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ES17151869T Active ES2807530T3 (es) | 2006-04-13 | 2007-04-11 | Mutantes mejorados de glucosa deshidrogenasa soluble dependiente de pirroloquinolina quinona |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US7732179B2 (cg-RX-API-DMAC7.html) |
| EP (2) | EP3246402B1 (cg-RX-API-DMAC7.html) |
| JP (3) | JP5683809B2 (cg-RX-API-DMAC7.html) |
| KR (1) | KR101168623B1 (cg-RX-API-DMAC7.html) |
| CN (1) | CN101421396B (cg-RX-API-DMAC7.html) |
| AU (1) | AU2007237478B2 (cg-RX-API-DMAC7.html) |
| BR (1) | BRPI0710131B1 (cg-RX-API-DMAC7.html) |
| CA (1) | CA2649135C (cg-RX-API-DMAC7.html) |
| ES (2) | ES2624805T3 (cg-RX-API-DMAC7.html) |
| HU (2) | HUE049911T2 (cg-RX-API-DMAC7.html) |
| MX (1) | MX2008013001A (cg-RX-API-DMAC7.html) |
| PL (2) | PL3246402T3 (cg-RX-API-DMAC7.html) |
| PT (2) | PT2010649T (cg-RX-API-DMAC7.html) |
| WO (1) | WO2007118647A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP5753720B2 (ja) * | 2010-04-22 | 2015-07-22 | アークレイ株式会社 | バイオセンサ |
| ES2568464T3 (es) | 2010-07-23 | 2016-04-29 | F. Hoffmann-La Roche Ag | Composiciones que contienen tampón zwiteriónico y usos en dispositivos y métodos electroanalíticos |
| WO2012095244A2 (en) | 2010-12-20 | 2012-07-19 | Lek Pharmaceuticals D.D. | Enzymatic synthesis of active pharmaceutical ingredient and intermediates thereof |
| EP2465936A1 (en) | 2010-12-20 | 2012-06-20 | LEK Pharmaceuticals d.d. | Enzymatic synthesis of statins and intermediates thereof |
| EP3901624B1 (en) | 2010-12-22 | 2024-01-31 | Roche Diabetes Care GmbH | Methods to compensate for sources of error during electrochemical testing |
| CN102559624B (zh) * | 2012-03-05 | 2013-10-16 | 浙江德清汇宁生物科技有限公司 | 一种吡咯喹啉醌依赖型葡萄糖脱氢酶的热稳定性突变体及其高通量筛选方法 |
| JP6111323B2 (ja) | 2012-04-19 | 2017-04-05 | エフ ホフマン−ラ ロッシュ アクチェン ゲゼルシャフト | 血液中の検体濃度を測定する方法および装置 |
| EP2811299A1 (en) | 2013-06-07 | 2014-12-10 | Roche Diagniostics GmbH | Test element for detecting at least one analyte in a body fluid |
| JP6998863B2 (ja) | 2015-09-25 | 2022-02-04 | エフ．ホフマン－ラ ロシュ アーゲー | 深共融溶媒におけるソルターゼａを利用したアミド基転移 |
| CN108138204B (zh) | 2015-09-25 | 2021-12-31 | 豪夫迈·罗氏有限公司 | 使用分选酶a生产硫酯的方法 |
| CN111073866B (zh) * | 2015-10-29 | 2024-03-19 | 英科隆生物技术（杭州）有限公司 | PQQ-sGDH突变体、聚核苷酸及其在葡萄糖检测中的应用 |
| CN105331590B (zh) * | 2015-10-29 | 2020-02-28 | 英科隆生物技术（杭州）有限公司 | 葡萄糖特异性改善的可溶性吡咯喹啉醌依赖性葡萄糖脱氢酶突变体、聚核苷酸及其应用 |
| EP3394252B1 (en) | 2015-12-21 | 2020-04-29 | F. Hoffmann-La Roche AG | Mutant 3-hydroxybutyrate dehydrogenase from alcaligenes faecalis as well as methods and uses involving the same |
| WO2017137491A1 (en) | 2016-02-09 | 2017-08-17 | Roche Diabetes Care Gmbh | Mutant 3-hydroxybutyrate dehydrogenase from rhodobacter sphaeroides as well as methods and uses involving the same |
| KR102372113B1 (ko) | 2016-10-05 | 2022-03-07 | 에프. 호프만-라 로슈 아게 | 다중 분석물 진단 테스트 엘리먼트들을 위한 검출 시약들 및 전극 배열들, 그리고 그것을 사용하는 방법들 |
| CN115820608B (zh) * | 2022-08-31 | 2024-06-04 | 中国海洋大学 | λ-卡拉胶酶突变体OUC-CglA-DPQQ及其应用 |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3716957A1 (de) | 1987-05-20 | 1988-12-01 | Boehringer Mannheim Gmbh | Expressionsvektor zur regulierbaren expression von fremdgenen in prokaryonten |
| DE4311464A1 (de) | 1993-04-08 | 1994-10-13 | Boehringer Mannheim Gmbh | Verfahren zur kolorimetrischen Bestimmung eines Analyten mit einer PQQ-abhängigen Dehydrogenase |
| DE19639169A1 (de) | 1996-09-24 | 1998-04-02 | Boehringer Mannheim Gmbh | Redoxaktive Verbindungen und deren Anwendung |
| JPH10243786A (ja) | 1997-03-03 | 1998-09-14 | Koji Hayade | 改変型グルコース脱水素酵素 |
| US5997817A (en) | 1997-12-05 | 1999-12-07 | Roche Diagnostics Corporation | Electrochemical biosensor test strip |
| JPH11243949A (ja) | 1998-03-03 | 1999-09-14 | Toyobo Co Ltd | Ｐｑｑを補欠分子族とするグルコースデヒドロゲナーゼおよびその製造方法 |
| JP2002538782A (ja) * | 1999-02-19 | 2002-11-19 | メルク パテント ゲゼルシャフト ミット ベシュレンクテル ハフトング | グルコースデヒドロゲナーゼ融合蛋白質及び発現システムにおけるそれらの使用 |
| JP2000350588A (ja) * | 1999-04-08 | 2000-12-19 | Koji Hayade | グルコース脱水素酵素 |
| TWI224136B (en) | 1999-04-30 | 2004-11-21 | Koji Sode | Glucose dehydrogenase |
| BRPI0114962B8 (pt) | 2000-10-27 | 2021-07-27 | Hoffmann La Roche | mutante de glicose desidrogenase solúvel (s-gdh) dependente de pirroloquinolina quinona (pqq), processo para detecção, determinação ou medição da glicose em uma amostra, e dispositivo para realização do mesmo |
| JP2004344145A (ja) * | 2002-05-27 | 2004-12-09 | Toyobo Co Ltd | 基質特異性または安定性に優れたピロロキノリンキノン（ｐｑｑ）依存性グルコースデヒドロゲナーゼ改変体 |
| JP2004173538A (ja) * | 2002-11-25 | 2004-06-24 | Amano Enzyme Inc | ピロロキノリンキノン依存性グルコース脱水素酵素 |
| RU2336306C1 (ru) | 2004-07-20 | 2008-10-20 | Ф.Хоффманн-Ля Рош Аг | Генетически сконструированная зависимая от пирролохинолинхинона глюкозодегидрогеназа, содержащая инсерцию аминокислоты |
-
2007
- 2007-04-11 ES ES07724148.7T patent/ES2624805T3/es active Active
- 2007-04-11 AU AU2007237478A patent/AU2007237478B2/en active Active
- 2007-04-11 ES ES17151869T patent/ES2807530T3/es active Active
- 2007-04-11 EP EP17151869.9A patent/EP3246402B1/en active Active
- 2007-04-11 MX MX2008013001A patent/MX2008013001A/es active IP Right Grant
- 2007-04-11 PL PL17151869T patent/PL3246402T3/pl unknown
- 2007-04-11 KR KR1020087025007A patent/KR101168623B1/ko active Active
- 2007-04-11 PT PT77241487T patent/PT2010649T/pt unknown
- 2007-04-11 HU HUE17151869A patent/HUE049911T2/hu unknown
- 2007-04-11 JP JP2009504634A patent/JP5683809B2/ja active Active
- 2007-04-11 EP EP07724148.7A patent/EP2010649B1/en active Active
- 2007-04-11 CN CN200780013259.8A patent/CN101421396B/zh active Active
- 2007-04-11 PL PL07724148T patent/PL2010649T3/pl unknown
- 2007-04-11 HU HUE07724148A patent/HUE032804T2/en unknown
- 2007-04-11 CA CA2649135A patent/CA2649135C/en active Active
- 2007-04-11 BR BRPI0710131-7A patent/BRPI0710131B1/pt active Search and Examination
- 2007-04-11 PT PT171518699T patent/PT3246402T/pt unknown
- 2007-04-11 WO PCT/EP2007/003207 patent/WO2007118647A1/en not_active Ceased
-
2008
- 2008-10-13 US US12/250,241 patent/US7732179B2/en active Active
-
2013
- 2013-06-21 JP JP2013130565A patent/JP5937547B2/ja active Active
-
2016
- 2016-02-08 JP JP2016022203A patent/JP6185617B2/ja active Active
Also Published As
| Publication number | Publication date |
|---|---|
| JP6185617B2 (ja) | 2017-08-23 |
| US7732179B2 (en) | 2010-06-08 |
| MX2008013001A (es) | 2008-10-17 |
| KR101168623B1 (ko) | 2012-08-03 |
| WO2007118647A1 (en) | 2007-10-25 |
| PT2010649T (pt) | 2017-05-03 |
| US20090148874A1 (en) | 2009-06-11 |
| HUE032804T2 (en) | 2017-11-28 |
| AU2007237478A1 (en) | 2007-10-25 |
| JP5683809B2 (ja) | 2015-03-11 |
| PL3246402T3 (pl) | 2020-10-19 |
| CN101421396A (zh) | 2009-04-29 |
| HUE049911T2 (hu) | 2020-11-30 |
| CN101421396B (zh) | 2016-01-20 |
| JP2013198497A (ja) | 2013-10-03 |
| HK1131633A1 (zh) | 2010-01-29 |
| KR20080106349A (ko) | 2008-12-04 |
| JP2016119904A (ja) | 2016-07-07 |
| EP2010649A1 (en) | 2009-01-07 |
| BRPI0710131B1 (pt) | 2020-03-10 |
| AU2007237478B2 (en) | 2011-05-19 |
| CA2649135C (en) | 2013-11-19 |
| EP2010649B1 (en) | 2017-03-08 |
| ES2807530T3 (es) | 2021-02-23 |
| PL2010649T3 (pl) | 2017-08-31 |
| JP5937547B2 (ja) | 2016-06-22 |
| JP2009533033A (ja) | 2009-09-17 |
| CA2649135A1 (en) | 2007-10-25 |
| EP3246402A1 (en) | 2017-11-22 |
| PT3246402T (pt) | 2020-07-14 |
| BRPI0710131A2 (pt) | 2011-08-02 |
| EP3246402B1 (en) | 2020-05-20 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES2624805T3 (es) | Mutantes mejorados de glucosa deshidrogenasa soluble dependiente de pirroloquinolina quinona | |
| ES2720287T3 (es) | Fructosil aminoácido oxidasa | |
| ES2502481T3 (es) | Composición para el análisis de proteínas glicosiladas | |
| US9062286B2 (en) | Amadoriase having altered substrate specificity | |
| US7816116B2 (en) | Modified creatinine amide hydrolase having improved affinity for substrate, and reagent composition for determination of creatinine | |
| Hao et al. | Acquired resistance to cisplatin and doxorubicin in a small cell lung cancer cell line is correlated to elevated expression of glutathione-linked detoxification enzymes | |
| US20150118700A1 (en) | Modified amadoriase reacting with fructosyl hexapeptide | |
| US20120171708A1 (en) | Modified flavin adenine dinucleotide-dependent glucose dehydrogenase | |
| EP3262182A1 (en) | Modified creatinase | |
| JP2020141690A (ja) | 糖化ペプチドに作用するアマドリアーゼを用いたＨｂＡ１ｃ測定法 | |
| JP2022081510A (ja) | ＨｂＡ１ｃデヒドロゲナーゼ | |
| JP6843740B2 (ja) | 比活性が向上したアマドリアーゼ | |
| US10752934B2 (en) | PQQ-sGDH mutant, polynucleotide and glucose detection biosensor | |
| Allocati et al. | Evaluation of the role of two conserved active-site residues in Beta class glutathione S-transferases | |
| Krautwurst et al. | Saccharomyces cerevisiae phosphoenolpyruvate carboxykinase: revised amino acid sequence, site-directed mutagenesis, and microenvironment characteristics of cysteines 365 and 458 | |
| CN105331590B (zh) | 葡萄糖特异性改善的可溶性吡咯喹啉醌依赖性葡萄糖脱氢酶突变体、聚核苷酸及其应用 | |
| CA2570593A1 (en) | Genetically engineered pyrroloquinoline quinone dependent glucose dehydrogenase comprising an amino acid insertion | |
| Ueki et al. | Characterization of vanadium-binding sites of the vanadium-binding protein Vanabin2 by site-directed mutagenesis | |
| JPWO2019045052A1 (ja) | 糖化ヘモグロビンオキシダーゼ改変体及び測定方法 | |
| KR20050042771A (ko) | 글루코오스 탈수소효소 | |
| Allocati et al. | Glutamic acid-65 is an essential residue for catalysis in Proteus mirabilis glutathione S-transferase B1-1 | |
| WO2005113761A2 (en) | Novel alanine transaminase enzymes and methods of use | |
| EP2748312A2 (en) | Cholesterol oxidase | |
| US7914985B2 (en) | Alanine transaminase enzymes and methods of use | |
| WO2005027725A2 (en) | Determination of ions using ion-sensitive enzymes |